Pharmacokinetics and pharmacodynamics of antibiotics in meningitis

D R Andes1, W A Craig

  • 1Department of Medicine, University of Wisconsin Medical School, Madison, USA. drandes@facstaff.wisc.edu

Insights

Achieving adequate antimicrobial concentrations in cerebrospinal fluid (CSF) is key for treating meningitis. Optimal dosing strategies, like extended or once-daily regimens, depend on the specific antibiotic and its properties for effective bacterial killing.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neuroscience

Background:

  • Cerebrospinal fluid (CSF) penetration by antimicrobials is crucial for treating central nervous system infections like meningitis.
  • Factors influencing antimicrobial penetration include lipid solubility, molecular size, efflux pumps, protein binding, and inflammation.

Purpose of the Study:

  • To review the penetration of various antimicrobials into the CSF.
  • To discuss the pharmacokinetic/pharmacodynamic (PK/PD) targets for achieving bactericidal activity.
  • To evaluate the efficacy of different dosing strategies for common antimicrobial classes.

Main Methods:

  • Literature review of antimicrobial penetration and efficacy in meningitis models.
  • Analysis of PK/PD parameters such as CSF/MIC ratios and time above MIC.
  • Comparison of once-daily versus multiple-daily dosing regimens for specific antibiotic classes.

Main Results:

  • Penicillins, cephalosporins, carbapenems, fluoroquinolones, vancomycin, and rifampin show high CSF penetration relative to the minimum bactericidal concentration (MBC).
  • For beta-lactams, maintaining CSF concentrations above the MBC for >50% of the dosing interval is critical.
  • Once-daily aminoglycoside dosing is effective in experimental meningitis due to prolonged effects, while fluoroquinolones are less effective with this regimen.

Conclusions:

  • Optimizing antimicrobial dosing in meningitis requires understanding drug-specific PK/PD properties and CSF penetration.
  • Time above MBC is crucial for beta-lactams, while peak/MBC and AUC/MBC ratios are important for aminoglycosides and fluoroquinolones.
  • Further research is needed to clarify the clinical impact of steroid co-administration on antimicrobial efficacy in human meningitis.

Related Concept Videos

Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...